13,811 Shares in Doximity, Inc. $DOCS Purchased by Dynamic Technology Lab Private Ltd

Key Points

• Dynamic Technology Lab Private Ltd made a new investment of approximately $801,000 in Doximity, acquiring 13,811 shares during the first quarter.
• Analyst ratings for Doximity include a mix of two Strong Buy, ten Buy, and eleven Hold ratings, with an average target price set at $66.21.
• Insider trading activity showed a significant decrease in ownership for two directors, with 32,000 shares sold in the past ninety days, valued at approximately $1.93 million.

Dynamic Technology Lab Private Ltd purchased a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 13,811 shares of the company's stock, valued at approximately $801,000.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Amalgamated Bank grew its stake in shares of Doximity by 0.3% in the first quarter. Amalgamated Bank now owns 60,928 shares of the company's stock worth $3,536,000 after purchasing an additional 186 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock worth $2,262,000 after purchasing an additional 210 shares in the last quarter. Greenleaf Trust grew its stake in shares of Doximity by 5.4% in the first quarter. Greenleaf Trust now owns 4,492 shares of the company's stock worth $261,000 after purchasing an additional 230 shares in the last quarter. Spire Wealth Management grew its stake in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after purchasing an additional 260 shares in the last quarter. Finally, Allworth Financial LP grew its stake in shares of Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after purchasing an additional 287 shares in the last quarter. Institutional investors own 87.19% of the company's stock.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded up $0.79 during midday trading on Friday, reaching $71.05. The company had a trading volume of 1,374,597 shares, compared to its average volume of 2,224,099. Doximity, Inc. has a 1-year low of $38.30 and a 1-year high of $85.21. The firm has a market cap of $13.31 billion, a price-to-earnings ratio of 71.05, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. The company has a fifty day simple moving average of $63.60 and a two-hundred day simple moving average of $59.77.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the business posted $0.28 earnings per share. Doximity's quarterly revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 10,000 shares of the stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Regina M. Benjamin sold 10,000 shares of the stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at $997,080. This trade represents a 37.57% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,000 shares of company stock worth $1,929,380 in the last quarter. 31.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Needham & Company LLC increased their price target on Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the company a "neutral" rating in a research note on Wednesday, May 21st. Wells Fargo & Company raised their target price on Doximity from $55.00 to $62.00 and gave the company an "equal weight" rating in a research note on Monday, August 4th. BTIG Research raised Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price for the company in a research note on Monday, June 2nd. Finally, JPMorgan Chase & Co. decreased their target price on Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research note on Tuesday, May 27th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, Doximity currently has a consensus rating of "Moderate Buy" and an average price target of $67.00.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.